Edition:
United States

People: Lannett Company Inc (LCI)

LCI on New York Consolidated

25.95USD
27 Apr 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$25.95
Open
$26.50
Day's High
$26.55
Day's Low
$25.50
Volume
935,974
Avg. Vol
942,034
52-wk High
$39.99
52-wk Low
$16.75

Farber, Jeffrey 

Mr. Jeffrey Farber is Chairman of the Board of the Company. He was appointed a Director of the Company in May 2006 and was appointed Chairman of the Board of Directors in July 2012. Jeffrey Farber joined the Company in August 2003 as Secretary. Since 1994, Mr. Farber has been President and the owner of Auburn Pharmaceutical (“Auburn”), a national generic pharmaceutical distributor. Prior to starting Auburn, Mr. Farber served in various positions at Major Pharmaceutical (“Major”), where he was employed for over 15 years. At Major, Mr. Farber was involved in sales, purchasing and eventually served as President of the Midwest division. Mr. Farber also spent time working at Major’s manufacturing division, Vitarine Pharmaceuticals, where he served on its Board of Directors. Mr. Farber joined the Board of Directors of the Karmanos Cancer Center in June 2015. The Karmanos Cancer Center is a not-for-profit national cancer center in Michigan. Mr. Farber graduated from Western Michigan University with a Bachelors of Science Degree in Business Administration and participated in the Pharmacy Management Graduate Program at Long Island University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable 22,500 --
Exercised -- --
Name Fiscal Year Total

Jeffrey Farber

--

Arthur Bedrosian

2,609,190

Martin Galvan

1,375,690

Robert Ehlinger

854,906

Kevin Smith

956,790

John Abt

584,137
As Of  29 Jun 2016